| Patrick William Frey, RPH | |
|
536 5th Ave, Antigo, WI 54409 | |
| (715) 623-2631 | |
| (715) 623-6887 |
| Full Name | Patrick William Frey |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 536 5th Ave, Antigo, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487735759 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 8169040 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Patrick William Frey, RPH W6980 Gruenberg Rd, Polar, WI 54418 Ph: (715) 623-7793 | Patrick William Frey, RPH 536 5th Ave, Antigo, WI 54409 Ph: (715) 623-2631 |
News Archive
Until now, patients with heart failure with preserved ejection fraction – the most common type of heart failure in the elderly – have had no access to evidenced-based treatments. For the first time, a large clinical trial led by Prof. Dr. Stefan Anker from Charité – Universitätsmedizin Berlin has identified a drug which has a distinctly positive effect on prognosis. In patients affected by this type of heart failure, the drug – empagliflozin – reduces the risk of hospitalization or cardiovascular death by 21 percent. The results of this research have been published in the New England Journal of Medicine.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results of a study "Percutaneous Tibial Nerve Stimulation Effects on Detrusor Overactivity Incontinence Are Not Due to a Placebo Effect A Randomized, Double-Blind, Placebo Controlled Trial," to be published in the November 2010 print edition of THE JOURNAL OF UROLOGY.
The multi-center study in Sweden and Norway with ChronSeal® is now finalized and the data are being analyzed in Sweden and by Kringle in Japan. ChronTech and Kringle have jointly decided that the results will be publicly available on May 27th. At follow-up of the ChronVac-C® -study where patients now have started treatment according to standard-of-care (interferon and ribavirin) all patients (100%) were virus free at treatment week 12 and 5/6 (83%) had less than 50 copies of virus/mL blood already at treatment week four.
"The number of people needing food aid in Zimbabwe will rise by 60 percent this year to 1.6 million, the World Food Programme [WFP] said on Friday, citing an annual assessment carried out by the United Nations and the Zimbabwean government," Reuters reports.
An international consortium led by researchers in Sweden and Switzerland has conducted a genome-wide study that the team is calling a "medical breakthrough" in malaria research.
› Verified 9 days ago
Paul Kirk Zwieg, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 E State Highway 64, Antigo, WI 54409 Phone: 715-627-1636 Fax: 715-627-7987 | |
Kristen M Mattmiller, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 E State Highway 64, Antigo, WI 54409 Phone: 715-627-1636 | |
James Gordon Schofield, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 536 5th Ave, Antigo, WI 54409 Phone: 715-623-2631 Fax: 715-623-6887 | |
Ms. Shannon Cori Duginski, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2204 Neva Rd, Antigo, WI 54409 Phone: 715-627-7430 Fax: 715-623-5003 | |
Jason Peter Cueny, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 E Highway 64, Antigo, WI 54409 Phone: 715-627-1636 | |
Tracey Grimek, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2204 Neva Rd, Antigo, WI 54409 Phone: 715-627-7430 |